WILL RUTLAND

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry NEW HAVEN, CT NPI 1194256271

General Payments — all program years on this page

$1,275.73

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 68
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $449.93 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $449.9320

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $285.6415
2023 $540.1633
2024 $449.9320

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1105991596 ABBVIE INC. $17.92 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105991598 ABBVIE INC. $19.06 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118973690 Otsuka America Pharmaceutical, Inc. $14.10 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118973692 Otsuka America Pharmaceutical, Inc. $23.98 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118973694 Otsuka America Pharmaceutical, Inc. $18.40 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120586999 Alkermes, Inc. $20.56 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120587003 Alkermes, Inc. $27.50 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120587007 Alkermes, Inc. $13.75 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137665968 Takeda Pharmaceuticals U.S.A., Inc. $24.70 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143311278 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.04 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143311282 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.03 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143311285 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $25.73 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145963616 Lundbeck LLC $28.02 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145963618 Lundbeck LLC $31.59 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145963620 Lundbeck LLC $27.92 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148328097 Axsome Therapeutics, Inc. $23.99 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148328099 Axsome Therapeutics, Inc. $16.78 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148328101 Axsome Therapeutics, Inc. $22.41 05/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150818346 Neurocrine Biosciences, Inc. $35.69 11/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150843952 Neurocrine Biosciences, Inc. $23.76 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.